LifeStance Health Group (NASDAQ:LFST) Earns “Outperform” Rating from William Blair

LifeStance Health Group (NASDAQ:LFST)‘s stock had its “outperform” rating reiterated by research analysts at William Blair in a research note issued to investors on Friday,RTT News reports. William Blair also issued estimates for LifeStance Health Group’s Q1 2025 earnings at ($0.03) EPS, Q2 2025 earnings at ($0.03) EPS, Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

LFST has been the subject of several other reports. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Monday, December 16th. Barclays raised their price objective on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat, LifeStance Health Group has an average rating of “Moderate Buy” and an average price target of $8.70.

LifeStance Health Group Trading Up 0.6 %

Shares of NASDAQ:LFST opened at $7.79 on Friday. LifeStance Health Group has a 52-week low of $4.64 and a 52-week high of $9.00. The company has a market capitalization of $2.98 billion, a P/E ratio of -29.96 and a beta of 1.28. The company has a 50-day simple moving average of $7.80 and a 200 day simple moving average of $7.23. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC increased its holdings in shares of LifeStance Health Group by 26.8% during the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock worth $24,170,000 after purchasing an additional 729,794 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock worth $7,731,000 after purchasing an additional 297,723 shares during the period. SG Americas Securities LLC increased its holdings in shares of LifeStance Health Group by 65.7% during the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock worth $666,000 after purchasing an additional 35,823 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of LifeStance Health Group by 13.0% during the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock worth $662,000 after purchasing an additional 10,894 shares during the period. Finally, Point72 Asset Management L.P. increased its holdings in shares of LifeStance Health Group by 24.9% during the third quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company’s stock worth $7,703,000 after purchasing an additional 219,329 shares during the period. 85.50% of the stock is owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.